GRETCHEN SCOTT: Open Payments
NPI 1336101849 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 18 payments from 12 companies in 2025. Trend: 2023 $112 · 2024 $227 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 6 | $103 |
| Ardelyx, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| NxStage Medical, Inc. | 1 | $19 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: IBSRELA, Vanrafia, TARPEYO, Kerendia, FABRAZYME, FUROSCIX, LIBERTY SELECT CYCLER, VELPHORO.
Industry payments across SD — which companies pay providers there.
